Lasofoxifene clearance may be increased in patients chronically treated with inducers of CYP3A4 and UGTs (eg, phenytoin, carbamazepine, barbiturates and St John’ s Wort) resulting in reduced steady-state concentrations and may result in reduced efficacy.